Crossmark

Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study

Crossref DOI link: https://doi.org/10.1007/s00280-018-3523-x

Published Online: 2018-01-30

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ohnuma, Hiroyuki https://orcid.org/0000-0002-4350-6971
Sato, Yasushi

Hirakawa, Masahiro

Kikuchi, Shohei

Miyanishi, Koji

Sagawa, Tamotsu

Takahashi, Yasuo

Nobuoka, Takayuki

Okamoto, Koichi

Miyamoto, Hiroshi

Takemasa, Ichiro

Takayama, Tetsuji

Kato, Junji
License Information

Text and Data Mining valid from 2018-01-30
More Information

Article History

Received: 1 September 2017

Accepted: 16 January 2018

First Online: 30 January 2018

Compliance with ethical standards

:

: The authors declare that they have no competing interests.

: None.

: This study was approved by the ethics committee of each participating hospital and was performed in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: For this type of study formal consent is not required.